TRANYLCYPROMINE (PARNATE) IN THE AMBULATORY TREATMENT OF DEPRESSED PATIENTS
Abstract
Tranylcypromine is a safe and potent mono-amine oxidase inhibitor which, when used in combination with sedatives, produced improvement in 74% of 84 ambulatory depressed patients of both psychotic and psychoneurotic types. The onset of benefit was rapid, occurring within an average of 7-9 days. The improvement was more rapid and more dramatic when the drug was combined with trifluoperazine. The incidence of significant side effects was low. No case of blood dyscrasia or jaundice occurred in our series. Some of these cases have been followed for over one year and have had no relapse.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
